ARCHIVES

NCI Advisors Criticize a Biomarker Study Touted as High Priority for NCI and FDA.

This article is from The Cancer Letter archive.

Vol. 33 No. 27 | July 13, 2007

Download PDF Visit The Full Archive

Related Articles

Clinical Trials Approved By NCI In November

December 28, 2001

Doctor-Patient Interaction May Cause Racial Disparity

February 24, 2006

Counseling reduces Pain, Study Shows

April 18, 1986

Broder To Leave In March; Sondik To Be Acting Director

January 27, 1995

Anil Potti Resigns From Duke University

November 19, 2010

Single-Letter Mutation Found Responsible For Waldenstrom’s

December 30, 2011